Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection

Zidovudine is an important component of first-line antiretroviral treatment regimens used to manage HIV and tuberculosis (TB) co-infection. Nail pigmentation is documented both in adult as well as pediatric HIV patients, but to the best of our knowledge, it has not been reported in 45-year-old women...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandon, Vishal R., Sadiq, Shamiya, Khajuria, Vijay, Mahajan, Annil, Sharma, Sudhaa, Gillani, Zahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832895/
https://www.ncbi.nlm.nih.gov/pubmed/27134481
http://dx.doi.org/10.4103/0976-7800.179176
_version_ 1782427300681220096
author Tandon, Vishal R.
Sadiq, Shamiya
Khajuria, Vijay
Mahajan, Annil
Sharma, Sudhaa
Gillani, Zahid
author_facet Tandon, Vishal R.
Sadiq, Shamiya
Khajuria, Vijay
Mahajan, Annil
Sharma, Sudhaa
Gillani, Zahid
author_sort Tandon, Vishal R.
collection PubMed
description Zidovudine is an important component of first-line antiretroviral treatment regimens used to manage HIV and tuberculosis (TB) co-infection. Nail pigmentation is documented both in adult as well as pediatric HIV patients, but to the best of our knowledge, it has not been reported in 45-year-old women of HIV/TB co-infection. Such an adverse drugs reactions (ADR), although is harmless and reversible, psychological aspects of such ADR may be immense to the extent that it can negatively affect the compliance and result in therapeutic failure. Thus, it is worth reporting.
format Online
Article
Text
id pubmed-4832895
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-48328952016-04-29 Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection Tandon, Vishal R. Sadiq, Shamiya Khajuria, Vijay Mahajan, Annil Sharma, Sudhaa Gillani, Zahid J Midlife Health Case Report Zidovudine is an important component of first-line antiretroviral treatment regimens used to manage HIV and tuberculosis (TB) co-infection. Nail pigmentation is documented both in adult as well as pediatric HIV patients, but to the best of our knowledge, it has not been reported in 45-year-old women of HIV/TB co-infection. Such an adverse drugs reactions (ADR), although is harmless and reversible, psychological aspects of such ADR may be immense to the extent that it can negatively affect the compliance and result in therapeutic failure. Thus, it is worth reporting. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4832895/ /pubmed/27134481 http://dx.doi.org/10.4103/0976-7800.179176 Text en Copyright: © Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Tandon, Vishal R.
Sadiq, Shamiya
Khajuria, Vijay
Mahajan, Annil
Sharma, Sudhaa
Gillani, Zahid
Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection
title Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection
title_full Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection
title_fullStr Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection
title_full_unstemmed Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection
title_short Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection
title_sort zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for hiv/tuberculosis co-infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832895/
https://www.ncbi.nlm.nih.gov/pubmed/27134481
http://dx.doi.org/10.4103/0976-7800.179176
work_keys_str_mv AT tandonvishalr zidovudineinducednailhyperpigmentationin45yearoldwomenprescribedforhivtuberculosiscoinfection
AT sadiqshamiya zidovudineinducednailhyperpigmentationin45yearoldwomenprescribedforhivtuberculosiscoinfection
AT khajuriavijay zidovudineinducednailhyperpigmentationin45yearoldwomenprescribedforhivtuberculosiscoinfection
AT mahajanannil zidovudineinducednailhyperpigmentationin45yearoldwomenprescribedforhivtuberculosiscoinfection
AT sharmasudhaa zidovudineinducednailhyperpigmentationin45yearoldwomenprescribedforhivtuberculosiscoinfection
AT gillanizahid zidovudineinducednailhyperpigmentationin45yearoldwomenprescribedforhivtuberculosiscoinfection

Ejemplares similares